Association between genetic polymorphisms related to DNA repair or xenobiotic pathways and gastric premalignant conditions

Anticancer Research

Volumn 31, Issue 4, 2011, Pages 1459-1465

  Tahara, Tomomitsu ^a   Shibata, Tomoyuki ^a   Nakamura, Masakatsu ^a   Yamashita, Hiromi ^a   Yoshioka, Daisuke ^a   Okubo, Masaaki ^a   Yonemura, Joh ^a   Kamiya, Yoshio ^a   Ishizuka, Takamitsu ^a   Nakagawa, Yoshihito ^a   Nagasaka, Mitsuo ^a   Iwata, Masami ^a   Hirata, Ichiro ^a   Arisawa, Tomiyasu ^b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric atrophy; GSTM1; GSTP1; GSTT1; Helicobacter pylori; Intestinal metaplasia; Polymorphism; XRCC1

Indexed keywords

ARGININE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; XRCC1 PROTEIN;

ADULT; AGED; ARTICLE; ATROPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA REPAIR; DUODENUM ULCER; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; RISK; STOMACH ATROPHY; STOMACH CANCER; STOMACH ULCER; XENOBIOTIC METABOLISM;

ASIAN CONTINENTAL ANCESTRY GROUP; DNA REPAIR; DNA-BINDING PROTEINS; DUODENAL ULCER; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; POLYMORPHISM, GENETIC; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS; STOMACH ULCER; TUMOR MARKERS, BIOLOGICAL; XENOBIOTICS;

EID: 79956134233     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. NIH Consensus Conference. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease: Helicobacter pylori in peptic ulcer disease. JAMA 272: 65-69, 1992.
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N and Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127-1131, 1991.
4. Huang JQ, Sridhar S, Chen Y and Hunt RH: Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 774: 1169-1179, 1998. (Pubitemid 28243902)
5. Blaser MJ and Parsonnet J: Parasitism by the 'slow' bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 94: 4-8, 1994.
6. Bagchi D, McGinn TR, Ye X, Bagchi M, Krohn RL, Chatterjee A and Stohs SJ: Helicobacter pylori-induced oxidative stress and DNA damage in a primary culture of human gastric mucosal cells. Dig Dis Sci 47: 1405-1412, 2002. (Pubitemid 34606647)
7. Ladeira MS, Rodrigues MA, Salvadori DM, Queiroz DM and Freire-Maia DV: DNA damage in patients infected by Helicobacter pylori. Cancer Epidemiol Biomarkers Prev 13: 631-637, 2004. (Pubitemid 38737900)
8. Loeb LA, Loeb KR and Anderson JP: Multiple mutations and cancer. Proc Natl Acad Sci USA 100: 776-781, 2003.
9. Obst B, Wagner S, Sewing KF and Beil W: Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis 21: 1111-1115, 2000. (Pubitemid 30389334)
10. Caldecott KW, Aoufouchi S, Johnson P and Shall S: XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res 24: 4387-4394, 1996.
11. Lindahl T: Suppression of spontaneous mutagenesis in human cells by DNA base excision-repair. Mutat Res 462: 129-135, 2000.
12. Christmann M, Tomicic MT, Roos WP and Kaina B: Mechanisms of human DNA repair: an update. Toxicology 193: 3-34, 2003. (Pubitemid 37340141)
13. Marintchev A, Mullen MA, Maciejewski MW, Pan B, Gryk MR and Mullen GP: Solution stmcture of the single-strand break repair protein XRCC1 N-terminal domain. Nat Struct Bio 16: 884-893, 1999. (Pubitemid 29415182)
14. Butkiewicz D, Rusin M, Harris CC and Chorazy M: Identification of four single nucleotide polymorphisms in DNA repair genes: XPA and XPB (ERCC3) in Polish population. Hum Mutat 75: 577-578, 2000.
15. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, Strom SS, Spitz MR and Wei Q: Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20: 2125-2129, 1999. (Pubitemid 29535314)
16. Abdel-Rahman SZ, Soliman AS, Bondy ML, Omar S, El-Badawy SA, Khaled HM, Seifeldin IA and Levin B: Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett 159: 79-86, 2000.
17. Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L, Wang X, Spitz MR and Wei Q: Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 88: 601-606, 2000.
18. Lee JM, Lee YC, Yang SY, Yang PW, Luh SP, Lee CJ, Chen CJ and Wu MT: Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer 95: 240-246, 2001.
19. Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse CK, Eaton A, Mohrenweiser HW, Newman B and Bell DA: Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 10: 217-222, 2001. (Pubitemid 34288532)
20. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L and Christiani DC: Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 12: 359-365, 2003. (Pubitemid 36427997)
21. Kettrer B: Protective role of GSH and GST in mutagenesis and carcinogenesis. Mutat Res 202: 343-361, 1988.
22. Hayes JD and Pulford DJ: The GST supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprevention and dmg resistance. Crit Rev Biochem Mol Biol 30: 445-600, 1995.
23. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B and Taylor JB: Human GST theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300: 271-276, 1994. (Pubitemid 24151046)
24. Ali-Osman F, Akande O, Antoun G, Mao JX and Buolamwini J: Molecular cloning, characterization and expression in E. coli of full-length cDNAs of 3 human glutathione-5-transferase Pi gene variants. J Biol Chem 272: 10004-100012, 1997.
25. Nakazato H, Suzuki K, Matsui H, Koike H, Okugi H, Ohtake N, Takei T, Nakata S, Hasumi M, Ito K, Kurokawa K and Yamanaka H: Association of genetic polymorphisms of GST genes (M1, T1, P1) with familial prostate cancer risk. Anticancer Res 23: 2897-2902, 2003.
26. Wang J, Deng Y, Chang J and Tokudoma S: GST genetic polymorphism and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 203: 185-193, 2003. (Pubitemid 37357168)
27. Dixon MF, Genta RM, Yardley JH and Correa P: International Workshop on the Histopathology of Gastritis, Houston 1994: Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 20: 1161-1181, 1996.
28. Harries LW, Stubbins MJ, Forman D, Howard GC and Wolf CR: Identification of genetic polymorphisms at the glutathione-5-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18: 641-644, 1997. (Pubitemid 28132446)
29. Abdel-Rahaman SZ, El-Zein RA, Anwar WA and Au WW: A multiplex PCR procedure for genetic polymorphism of the GSTM1 and GSTT1 genes in human. Cancer Lett 707: 229-233, 1996. (Pubitemid 26381994)
30. Ketterer B, Meyer DJ, Coles B, Taylor JB and Pemble S: Glutathione transferases and carcinogenesis. Basic Life Sci 39: 103-126, 1986.
31. Coles BF, Chen G, Kadlubar FF and Radominska-Pandya A: Interindividual variation and organ-specific patterns of glutathione S-transferase α, μ and expression in gastrointestinal tract mucosa of normal individuals. Arch Biochem Biophys 403: 270-276, 2002.
32. Shiotani A, Iishi H, Uedo N, Kumamoto M, Nakae Y, Ishiguro S, Tatsuta M and Graham DY: Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer 115: 463-469, 2005. (Pubitemid 40663752)
33. Oda Y, Kobayashi M, Ooi A, Muroishi Y and Nakanishi I: Genotypes of glutamione S-transferase M1 and N-acetyltransferase 2 in Japanese patients with gastric cancer. Gastric Cancer 2: 158-164, 1999.
34. Wang H, Zhou Y, Zhuang W, Yin YQ, Liu GJ, Wu TX, Yao X, Du L, Wei ML and Wu XT: Glutathione S-transferase M1 null genotype associated with gastric cancer among Asians. Dig Dis Sci 55: 1824-1830, 2010.
35. Chen B, Cao L, Zhou Y, Yang P, Wan HW, Jia GQ, Liu L and Wu XT: Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiologic studies. Dig Dis Sci 55: 1831-1838, 2010.
36. Correa P: Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 19(Suppl 1): S37-43, 1995.
37. El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C and McColl KE: Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 709: 681-691, 1995.
38. Lee S, Iida M, Yao T, Shindo S, Nose Y, Akazawa K, Okabe H and Fujishima M: Risk of gastric cancer in patients with non-surgically treated peptic ulcer. Scand J Gastroenterol 25: 1223-1226, 1990.
39. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ; American Cancer Society: Cancer statistics 2004, CA Cancer J Clin 54: 8-29, 2004.
40. Ekstrom AM, Held M, Hansson LE, Engstrand L and Nyren O: Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 121: 784-791, 2001. (Pubitemid 32959388)
41. Forman D, Weeb P and Parsonnet J: H. pylori and gastric cancer. Lancet 343: 243-244, 1994.
42. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Hamma K, Sumii K and Kajiyama G: Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6: 639-642, 1997. (Pubitemid 27342688)
43. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK and Chen JS; China Gastric Cancer Study Group: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291: 187-194, 2004. (Pubitemid 38082812)
44. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S and Asaka M; Japan Gast Study Group: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372: 392-397, 2008.
45. Hosokawa O, Tsuda S, Kidani E, Watanabe K, Tanigawa Y, Shirasaki S, Hayashi H and Hinoshita T: Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy 30: 721-723, 1998.
46. Chen SY, Liu TY, Shun CT, Wu MS, Lu TH, Lin JT, Sheu JC, Santella RM and Chen CJ: Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer. Int J Cancer 108: 606-612, 2004. (Pubitemid 38036664)
47. You WC, Hong JY, Zhang L, Pan KF, Pee D, Li JY, Ma JL, Rothman N, Caporaso N, Fraumeni JF Jr., Xu GW and Gail MH: Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population. Cancer Epidemiol Biomarkers Prev 74: 451-458, 2005. (Pubitemid 40270111)